Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Net Income towards Common Stockholders (2021 - 2025)

Tenon Medical (TNON) has 5 years of Net Income towards Common Stockholders data on record, last reported at -$3.4 million in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders fell 5.51% year-over-year to -$3.4 million; the TTM value through Sep 2025 reached -$13.1 million, up 4.98%, while the annual FY2024 figure was -$13.8 million, 12.37% up from the prior year.
  • Net Income towards Common Stockholders reached -$3.4 million in Q3 2025 per TNON's latest filing, down from -$2.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$200000.0 in Q1 2021 and bottomed at -$7.9 million in Q4 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$3.4 million, with a median of -$3.3 million recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 1076.5% in 2022, then surged 60.13% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$2.2 million in 2021, then tumbled by 256.28% to -$7.9 million in 2022, then soared by 60.13% to -$3.2 million in 2023, then dropped by 0.47% to -$3.2 million in 2024, then decreased by 6.9% to -$3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$3.4 million in Q3 2025, -$2.9 million in Q2 2025, and -$3.7 million in Q1 2025.